Share This Page
Patent: 10,632,112
✉ Email this page to a colleague
Summary for Patent: 10,632,112
Title: | Combination therapy for treatment of HBV infections |
Abstract: | Provided herein is a combination therapy comprising a compound of Formula I and peginterferon alfa-2a, or another interferon analog. The combination therapy is useful for the treatment of HBV infection. Also provided herein are compositions comprising a compound of Formula I and peginterferon alfa-2a, or another interferon analog. |
Inventor(s): | Hartman; George D. (Lansdale, PA) |
Assignee: | NOVIRA THERAPEUTICS, INC. (Doylestown, PA) |
Application Number: | 16/235,210 |
Patent Claims: | see list of patent claims |
Patent landscape, scope, and claims summary: | Analyzing the Claims and Patent Landscape of United States Patent 10,632,112 IntroductionWhen analyzing a patent, particularly one like United States Patent 10,632,112, it is crucial to delve into the specifics of the claims, the patent landscape, and the legal framework that governs patent law in the United States. This analysis will help in understanding the scope, validity, and potential challenges associated with the patent. Understanding Patent ClaimsDefinition and PurposePatent claims are the heart of a patent application, as they define the scope of the invention and the rights granted to the patentee. According to 35 U.S.C. §112(b), claims must "particularly point out and distinctly claim the subject matter which the applicant regards as the invention"[3]. Types of ClaimsClaims can be independent or dependent. Independent claims stand alone and define the invention without reference to other claims, while dependent claims refer back to and further limit an independent claim. The clarity and precision of these claims are critical, as they must inform those skilled in the art about the scope of the invention with reasonable certainty[5]. Definiteness RequirementThe definiteness requirement under 35 U.S.C. §112(b) mandates that claims must be clear and precise enough for a person skilled in the art to understand the scope of the invention. If claims are deemed indefinite, they can be held invalid. The courts construe claims as a matter of law, considering the specification and prosecution history to determine their meaning and scope[5]. Determining InventorshipConception and Reduction to PracticeInventorship in U.S. patent law is determined by identifying who conceived the idea or subject matter of the patent claims. Conception is the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention. Reduction to practice, while important, does not alone qualify someone as an inventor unless they also contributed to the conception[1]. Collaborative EffortsInventorship can involve multiple individuals who collaborate to produce the invention. However, contributions such as reducing the invention to practice or performing routine experiments do not qualify someone as an inventor unless they also conceived part of the invention[1]. Patent Term Adjustments and Double PatentingPatent Term Adjustments (PTA)Patent Term Adjustments (PTA) compensate applicants for delays caused by the Patent Office during prosecution, extending the patent term up to three years. However, these adjustments can interact with the doctrine of obviousness-type double patenting (ODP), which prevents a subsequent patent from being granted on the same invention or an obvious modification of an earlier granted patent[2]. Obviousness-Type Double Patenting (ODP)The Federal Circuit has emphasized that U.S. patent law entitles an inventor to only one patent on each invention. If multiple patents on the same invention are sought, a terminal disclaimer must be filed to disclaim any term that would extend the term of an already-issued patent. Failure to do so can result in the invalidation of subsequent patents due to ODP[2]. Drafting a Patent ApplicationKey AttributesA well-written patent application should describe the invention in a way that one of ordinary skill in the art can understand and replicate. It must disclose the best mode of carrying out the invention, provide support for claims, and ensure that claims are neither too narrow nor too broad to avoid prior art and design-around issues[3]. Claims and SpecificationClaims must be supported by the specification, which includes a detailed description of the invention, drawings, and background information. The specification and claims must work together to provide a clear and enabling description of the invention[3]. Legal Requirements for PatentabilityUtility, Novelty, and NonobviousnessFor a patent to be granted, the invention must meet the requirements of utility (35 U.S.C. §101), novelty (35 U.S.C. §102), and nonobviousness (35 U.S.C. §103). The invention must be useful, new, and not obvious to one skilled in the art[3]. Enablement and Best ModeThe specification must enable any person skilled in the art to make and use the invention (35 U.S.C. §112(a)). It must also set forth the best mode contemplated by the inventor for carrying out the invention[3]. Critical Analysis of United States Patent 10,632,112Claim ConstructionTo critically analyze the claims of this patent, one must construe the claims as a matter of law, considering the specification, drawings, and prosecution history. Any disputes over the meaning or scope of the claims would be resolved by looking at these sources to ensure the claims provide reasonable certainty in defining what is patented[5]. Inventorship and ContributionIt is essential to verify the inventorship of the patent, ensuring that only those who conceived the subject matter of the claims are listed as inventors. Any errors in inventorship can have serious consequences, including the invalidation of the patent if there was deceptive intent[1]. Patent Term and Double PatentingIf the patent has received a Patent Term Adjustment, it is crucial to ensure that it does not run afoul of the ODP doctrine. This involves checking if any terminal disclaimers were filed and if the patent claims are patentably distinct from earlier granted patents[2]. Challenges and Potential IssuesIndefiniteness and AmbiguityClaims that are indefinite or ambiguous can be challenged and potentially invalidated. The courts have strict standards for claim definiteness, and any failure to meet these standards can result in the claims being held invalid[5]. Prior Art and Design-AroundThe patent application must ensure that the claims are broad enough to cover the invention but not so broad as to encompass prior art. Narrow claims can limit the scope of protection and make it easier for others to design around the patent[3]. ConclusionAnalyzing the claims and patent landscape of United States Patent 10,632,112 involves a thorough examination of the legal requirements, claim construction, inventorship, and potential challenges such as indefiniteness and double patenting. Ensuring that the patent meets all statutory requirements and is free from errors in inventorship and claim drafting is crucial for its validity and enforceability. Key Takeaways
FAQsWhat is the significance of claim definiteness in patent law?Claim definiteness is crucial as it ensures that the scope of the invention is clearly defined, allowing those skilled in the art to understand what is patented. Indefinite claims can be invalidated[5]. How is inventorship determined in U.S. patent law?Inventorship is determined by identifying who conceived the idea or subject matter of the patent claims. Conception is the key step, and reduction to practice alone does not qualify someone as an inventor[1]. What is the purpose of a terminal disclaimer in patent law?A terminal disclaimer is filed to disclaim any term in a subsequent patent application that would extend the term of an already-issued patent, avoiding issues with obviousness-type double patenting[2]. What are the key attributes of a well-written patent application?A well-written patent application should describe the invention clearly, disclose the best mode, provide support for claims, and ensure claims are neither too narrow nor too broad[3]. How do Patent Term Adjustments interact with the doctrine of obviousness-type double patenting?PTAs can extend the patent term, but they must be managed carefully to avoid ODP issues. Terminal disclaimers may be necessary to ensure that subsequent patents do not improperly extend the term of an earlier patent[2]. Sources
More… ↓ |
Details for Patent 10,632,112
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Kadmon Pharmaceuticals Llc | INFERGEN | interferon alfacon-1 | Injection | 103663 | October 06, 1997 | ⤷ Try for Free | 2034-02-05 |
Biogen Inc. | PLEGRIDY | peginterferon beta-1a | Injection | 125499 | August 15, 2014 | ⤷ Try for Free | 2034-02-05 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |